Amarin Corp. (AMRN) Tops Q4 EPS by 4c, Revs Beat; Reaffirms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Amarin Reports Record Fourth Quarter and Full Year 2019 Financial Results and Provides Update on Operations
February 25, 2020 4:06 PM ESTRecord Revenue of $429.8 Million and $143.3 Million for Full Year and Fourth Quarter 2019Â Â
Launch Commenced of VASCEPA® as First and Only Drug with Its New Cardiovascular Risk Reduction Indication
Management to Host Conference Call at 4:30 p.m. ET Today
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today announced financial results for the quarter and year ended December 31, 2019 and provided an update on company operations.
Key Amarin recent achievements... More
